Aurora Spine Corporation
ASAPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 21% | -2.4% | 41.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 60.5% | 56.5% | 52.5% | 45.8% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 1% | -3.1% | -3.4% | -14.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5.4% | -11.6% | -10.5% | -23.9% |
| EPS Diluted | -0.012 | -0.024 | -0.023 | -0.043 |
| % Growth | 48.3% | -1.7% | 45.5% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |